Halozyme Therapeutics
HALO
#2095
Rank
C$10.79 B
Marketcap
$84.87
Share price
2.23%
Change (1 day)
65.10%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$2.31 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are C$2.31 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$2.18 B-3.56%
2022-12-31C$2.26 B96.14%
2021-12-31C$1.15 B111.49%
2020-12-31C$0.54 B-11.69%
2019-12-31C$0.61 B137.55%
2018-12-31C$0.26 B-33.46%
2017-12-31C$0.39 B-0.85%
2016-12-31C$0.39 B105.21%
2015-12-31C$0.19 B33.12%
2014-12-31C$0.14 B11.56%
2013-12-31C$0.12 B51.81%
2012-12-31C$85.39 M53.03%
2011-12-31C$55.8 M-21.37%
2010-12-31C$70.96 M-3.99%
2009-12-31C$73.91 M-0.64%
2008-12-31C$74.39 M63.2%
2007-12-31C$45.58 M70.14%
2006-12-31C$26.79 M899.02%
2005-12-31C$2.68 M41.36%
2004-12-31C$1.89 M434.82%
2003-12-31C$0.35 M-63.19%
2002-12-31C$0.96 M18291.97%
2001-12-31C$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.93 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$85.29 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.89 B 1,017.14%๐Ÿ‡บ๐Ÿ‡ธ USA
C$178.43 B 7,599.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.67 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
C$150.48 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA